Berberine inhibits cell growth and mediates caspase-independent cell death in human pancreatic cancer cells

Planta Medica

Volumn 76, Issue 11, 2010, Pages 1155-1161

  Pinto Garcia, Lina ^a   Efferth, Thomas ^b   Torres, Amada ^a   Hoheisel, Jrg D ^a   Youns, Mahmoud ^a,b,c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c Ein Helwan   (Egypt)

Author keywords

berberine; cell death; microarray; pancreatic cancer; photodynamic therapy

Indexed keywords

BERBERINE; BRCA1 PROTEIN; CASPASE; CASPASE 3; CASPASE 7; MESSENGER RNA; PROTEIN P53;

ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL PROLIFERATION; CYTOTOXICITY; DNA DAMAGE; DRUG MECHANISM; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PANCREAS CANCER;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BERBERINE; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME ACTIVATION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREATIC NEOPLASMS; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 77955043937     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0030-1249931     Document Type: Article

References (47)

1. Bezakova L, Misik V, Malekova L, Svajdlenka E, Kostalova D. Lipoxygenase inhibition and antioxidant properties of bisbenzylisoqunoline alkaloids isolated from Mahonia aquifolium. Pharmazie 1996 51 758-761
2. Misik V, Bezakova L, Malekova L, Kostalova D. Lipoxygenase inhibition and antioxidant properties of protoberberine and aporphine alkaloids isolated from Mahonia aquifolium. Planta Med 1995 61 372-373
3. Kraft K, Hobbs H. Pocket guide to herbal medicine. Stuttgart Georg Thieme Verlag 2004
4. Lans C, Turner N, Khan T, Brauer G, Boepple W. Ethnoveterinary medicines used for ruminants in British Columbia, Canada. J Ethnobiol Ethnomed 2007 3 11
5. Zhu X Z., Li X Y., Liu J. Recent pharmacological studies on natural products in China. Eur J Pharmacol 2004 500 221-230
6. Imanshahidi M, Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res 2008 22 999-1012
7. Zha W, Liang G, Xiao J, Studer E J., Hylemon P B., Pandak W M., Wang G, Li X, Zhou H. Berberine inhibits HIV protease inhibitor-induced inflammatory response by modulating ER stress signaling pathways in murine macrophages. PLoS One 2010 5 e9069
8. Pasqual M S., Lauer C P., Moyna P, Henriques J A. Genotoxicity of the isoquinoline alkaloid berberine in prokaryotic and eukaryotic organisms. Mutat Res 1993 286 243-252
9. Jantova S, Letasiova S, Brezova V, Cipak L, Labaj J. Photochemical and phototoxic activity of berberine on murine fibroblast NIH-3T3 and Ehrlich ascites carcinoma cells. J Photochem Photobiol B 2006 85 163-176
10. Lin C C., Yang J S., Chen J T., Fan S, Yu F S., Yang J L., Lu C C., Kao M C., Huang A C., Lu H F., Chung J G. Berberine induces apoptosis in human HSC-3 oral cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway. Anticancer Res 2007 27 3371-3378
11. Lin J P., Yang J S., Lee J H., Hsieh W T., Chung J G. Berberine induces cell cycle arrest and apoptosis in human gastric carcinoma SNU-5 cell line. World J Gastroenterol 2006 12 21-28
12. Mantena S K., Sharma S D., Katiyar S K. Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. Mol Cancer Ther 2006 5 296-308
13. Mantena S K., Sharma S D., Katiyar S K. Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP. Carcinogenesis 2006 27 2018-2027
14. Piyanuch R, Sukhthankar M, Wandee G, Baek S J. Berberine, a natural isoquinoline alkaloid, induces NAG-1 and ATF3 expression in human colorectal cancer cells. Cancer Lett 2007 258 230-240
15. Serafim T L., Oliveira P J., Sardao V A., Perkins E, Parke D, Holy J. Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line. Cancer Chemother Pharmacol 2008 61 1007-1018
16. Katiyar S K., Meeran S M., Katiyar N, Akhtar S. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Mol Carcinogen 2009 48 24-37
17. Liu Z, Liu Q, Xu B, Wu J, Guo C, Zhu F, Yang Q, Gao G, Gong Y, Shao C. Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage. Mutat Res 2009 662 75-83
18. Lin H L., Liu T Y., Lui W Y., Chi C W. Up-regulation of multidrug resistance transporter expression by berberine in human and murine hepatoma cells. Cancer 1999 85 1937-1942
19. Kim J B., Ko E, Han W, Shin I, Park S Y., Noh D Y. Berberine diminishes the side population and ABCG2 transporter expression in MCF-7 breast cancer cells. Planta Med 2008 74 1693-1700
20. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M J. Cancer statistics, 2009. CA Cancer J Clin 2009 59 225-249
21. Li J, Saif M W. Any progress in the management of advanced pancreatic cancer? Highlights from the 45th ASCO annual meeting, Orlando, FL; 2009. JOP 2009 10 361-365
22. Burris 3rd H A., Moore M J., Andersen J, Green M R., Rothenberg M L., Modiano M R., Cripps M C., Portenoy R K., Storniolo A M., Tarassoff P, Nelson R, Dorr F A., Stephens C D., Von Hoff D D. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997 15 2403-2413
23. Rivera F, Lopez-Tarruella S, Vega-Villegas M E., Salcedo M. Treatment of advanced pancreatic cancer: from gemcitabine single agent to combinations and targeted therapy. Cancer Treat Rev 2009 35 335-339
24. Youns M, Efferth T, Reichling J, Fellenberg K, Bauer A, Hoheisel J D. Gene expression profiling identifies novel key players involved in the cytotoxic effect of artesunate on pancreatic cancer cells. Biochem Pharmacol 2009 78 273-283
25. Esposito I, Bauer A, Hoheisel J D., Kleeff J, Friess H, Bergmann F, Rieker R J., Otto H F., Kloppel G, Penzel R. Microcystic tubulopapillary carcinoma of the pancreas: a new tumor entity? Virchows Arch 2004 444 447-453
26. Boujrad H, Gubkina O, Robert N, Krantic S, Susin S A. AIF-mediated programmed necrosis: a highly regulated way to die. Cell Cycle 2007 6 2612-2619
27. Agnello M, Morici G, Rinaldi A M. A method for measuring mitochondrial mass and activity. Cytotechnology 2008 56 145-149
28. Hara A, Iizuka N, Hamamoto Y, Uchimura S, Miyamoto T, Tsunedomi R, Miyamoto K, Hazama S, Okita K, Oka M. Molecular dissection of a medicinal herb with anti-tumor activity by oligonucleotide microarray. Life Sci 2005 77 991-1002
29. Iizuka N, Oka M, Yamamoto K, Tangoku A, Miyamoto K, Miyamoto T, Uchimura S, Hamamoto Y, Okita K. Identification of common or distinct genes related to antitumor activities of a medicinal herb and its major component by oligonucleotide microarray. Int J Cancer 2003 107 666-672
30. Ramachandran C, Rodriguez S, Ramachandran R, Raveendran Nair P K., Fonseca H, Khatib Z, Escalon E, Melnick S J. Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines. Anticancer Res 2005 25 3293-3302
31. Mathiasen I S., Jaattela M. Triggering caspase-independent cell death to combat cancer. Trends Mol Med 2002 8 212-220
32. Maiti M, Kumar G S. Molecular aspects on the interaction of protoberberine, benzophenanthridine, and aristolochia group of alkaloids with nucleic acid structures and biological perspectives. Med Res Rev 2007 27 649-695
33. Pereira G C., Branco A F., Matos J A., Pereira S L., Parke D, Perkins E L., Serafim T L., Sardao V A., Santos M S., Moreno A J., Holy J, Oliveira P J. Mitochondrially targeted effects of berberine [Natural Yellow 18,5,6-dihydro-9,10-dimethoxybenzo(g)-1,3-benzodioxolo(5,6-a) quinolizinium] on K1735-M2 mouse melanoma cells: comparison with direct effects on isolated mitochondrial fractions. J Pharmacol Exp Ther 2007 323 636-649
34. Tsang C M., Lau E P., Di K, Cheung P Y., Hau P M., Ching Y P., Wong Y C., Cheung A L., Wan T S., Tong Y, Tsao S W., Feng Y. Berberine inhibits Rho GTPases and cell migration at low doses but induces G2 arrest and apoptosis at high doses in human cancer cells. Int J Mol Med 2009 24 131-138
35. Gemin A, Sweet S, Preston T J., Singh G. Regulation of the cell cycle in response to inhibition of mitochondrial generated energy. Biochem Biophys Res Commun 2005 332 1122-1132
36. Krishnan P, Bastow K F. The 9-position in berberine analogs is an important determinant of DNA topoisomerase II inhibition. Anticancer Drug Des 2000 15 255-264
37. Letasiova S, Jantova S, Miko M, Ovadekova R, Horvathova M. Effect of berberine on proliferation, biosynthesis of macromolecules, cell cycle and induction of intercalation with DNA, dsDNA damage and apoptosis in Ehrlich ascites carcinoma cells. J Pharm Pharmacol 2006 58 263-270
38. Sun Y, Xun K, Wang Y, Chen X. A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anticancer Drugs 2009 20 757-769
39. Debnath D, Kumar G S., Nandi R, Maiti M. Interaction of berberine chloride with deoxyribonucleic acids: evidence for base and sequence specificity. Indian J Biochem Biophys 1989 26 201-208
40. Letasiova S, Jantova S, Muckova M, Theiszova M. Antiproliferative activity of berberine in vitro and in vivo. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2005 149 461-463
41. Konkimalla V B., Efferth T. Inhibition of epidermal growth factor receptor over-expressing cancer cells by the aphorphine-type isoquinoline alkaloid, dicentrine. Biochem Pharmacol 2010 79 1092-1099
42. Efferth T, Fabry U, Osieka R. Apoptosis and resistance to daunorubicin in human leukemic cells. Leukemia 1997 11 1180-1186
43. Johansson M, Persson J L. Cancer therapy: targeting cell cycle regulators. Anticancer Agents Med Chem 2008 8 723-731
44. Efferth T, Fabry U, Glatte P, Osieka R. Expression of apoptosis-related oncoproteins and modulation of apoptosis by caffeine in human leukemic cells. J Cancer Res Clin Oncol 1995 121 648-656
45. Wong A, Soo R A., Yong W P., Innocenti F. Clinical pharmacology and pharmacogenetics of gemcitabine. Drug Metab Rev 2009 41 77-88
46. Bergman A M., Pinedo H M., Peters G J. Determinants of resistance to 2,2-difluorodeoxycytidine (gemcitabine). Drug Resist Updat 2002 5 19-33
47. Kroep J R., Loves W J., van der Wilt C L., Alvarez E, Talianidis I, Boven E, Braakhuis B J., van Groeningen C J., Pinedo H M., Peters G J. Pretreatment deoxycytidine kinase levels predict in vivo gemcitabine sensitivity. Mol Cancer Ther 2002 1 371-376